Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28264866 | 0.98 | GAA (0.43) | GAAMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL28986081 | 0.98 | GAA (0.43) | GAAMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL12471147 | 0.88 | GAA (0.41) | GAAMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL3041192 | 0.88 | GAA (0.41) | GAAMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL28173102 | 0.88 | GAA (0.35) | GAAMAPT | |
| SCHEMBL11611273 | 0.84 | GAA (0.39) | GAAMAPT | |
| SCHEMBL11611264 | 0.84 | GAA (0.39) | GAAMAPT | |
| SCHEMBL28596071 | 0.83 | MAPT (0.36) | GAAMAPTMEN1KMT2AALDH1A1 | |
| Benzodiazepine SCHEMBL28173103 | 0.82 | GAA (0.32) | GAAMAPT | |
| SCHEMBL29415525 | 0.77 | GAA (0.48) | GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 577 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122071492-A | Organic electroluminescent material and device | 环球展览公司 | 2026-05-22 | — | — | CN | claimed |
| CN-122071494-A | Organic electroluminescent material and device | 环球展览公司 | 2026-05-22 | — | — | CN | claimed |
| CN-112236434-B | Polycyclic compound and organic light emitting device including the same | 株式会社LG化学 | 2024-02-23 | — | — | CN | claimed |
| US-20240052256-A1 | BENZAZEPINE COMPOUNDS AS ANTIOXIDANTS FOR LUBRICANT COMPOSITIONS | THE LUBRIZOL CORPORATION | 2024-02-15 | — | — | US | claimed |
| EP-4267707-A1 | BENZAZEPINE COMPOUNDS AS ANTIOXIDANTS FOR LUBRICANT COMPOSITIONS | The Lubrizol Corporation (US) | 2023-11-01 | — | — | EP | claimed |
| CN-116685663-A | Benzazepine compounds as antioxidants for lubricating compositions | 路博润公司 | 2023-09-01 | — | — | CN | claimed |
| WO-2022140496-A1 | BENZAZEPINE COMPOUNDS AS ANTIOXIDANTS FOR LUBRICANT COMPOSITIONS | THE LUBRIZOL CORPORATION (US) | 2022-06-30 | — | — | WO | claimed |
| CN-113861128-A | Polymerizable compound and optically anisotropic body | 江苏创拓新材料有限公司 | 2021-12-31 | — | — | CN | claimed |
| CN-103214431-A | 2,3-dihydrobenzazapine*compound or its salt and its medical application | UNIV FUDAN | 2013-07-24 | — | — | CN | claimed |
| EP-1852420-B1 | Indole compounds for treating respiratory disorders | ONO PHARMACEUTICAL CO (JP) | 2012-10-17 | — | — | EP | claimed |
| US-8153625-B2 | Nitrogen-containing heterocyclic compounds and medicinal use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2012-04-10 | — | — | US | claimed |
| US-7759336-B2 | Nitrogen-containing heterocyclic compounds and medicinal use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-07-20 | — | — | US | claimed |
| US-20030018056-A1 | Substituted guanidine derivatives | SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) | 2003-01-23 | — | — | US | claimed |
| EP-1238971-A1 | SUBSTITUTED GUANIDINE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2002-09-11 | — | — | EP | claimed |
| US-5753677-A | Benzoheterocyclic compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-05-19 | — | — | US | claimed |
| EP-0450097-B1 | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMA CO LTD (JP) | 1996-04-24 | — | — | EP | claimed |
| JP-8059624-A | — | — | None | — | — | JP | disclosed |
| CN-122071494-A | Organic electroluminescent material and device | 环球展览公司 | 2026-05-22 | — | — | CN | disclosed |
| US-4265890-A | ANTIPSYCHOTIC, ANTIEMETICS | SMITHKLINE CORPORATION (US) | 1981-05-05 | — | — | US | disclosed |
| EP-0007070-A1 | 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity | SMITHKLINE BECKMAN CORPORATION (US) | 1980-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030018056-A1 | Substituted guanidine derivatives | SLC28A1, SLC7A1, ABCB11 | GAA 292/4885MAPT 4395/4885MEN1 2803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.